Vascular Surgery Products

A line of products designed to provide a gentle approach to the treatment of vascular inflammation and infections, for care, topical and systemic treatment of ‘Circulatory and microcirculatory failure, venous stasis, edema, of Ulcers and of Diabetic Foot

All products of this line are constituted by an association of active ingredients, and optimal dosages to ensure a rapid therapeutic effect.

RSS Journal of Vascular Surgery

  • Discrepancies in Research Productivity Among Canadian Surgical Specialties October 1, 2019
    Explore differences in publication metrics between surgical specialties in Canada to establish benchmarks and identify predictors of productivity.
    Han Wang, Michael W.A. Chu, Luc Dubois
  • Effective Post-EVAR Surveillance and Management of Graft Complications Among Rural Inhabitants in Manitoba October 1, 2019
    All aortic surgery in Manitoba occurs in Winnipeg at two university hospitals. Given the large geographic catchment area, we hypothesized that patients living rurally would have inferior surveillance after endovascular aortic aneurysm repair (EVAR). We sought to determine if post-EVAR surveillance and endoleak management differed between urban and rural inhabitants.
    Matt Cwinn, Tarik Leylek, Gregory Harding, Joshua Koulack, April Boyd
  • Information for readers October 1, 2019
    Communications regarding original articles and editorial management should be addressed to Peter Gloviczki, MD, and Peter F. Lawrence, MD, Editors, Journal of Vascular Surgery, 9400 W. Higgins Road, Suite 315, Rosemont IL 60018; telephone: 312-334-2355; fax: 312-334-2320; e-mail: Information for authors appears in the January and July issues, at, and at Authors […]
  • The Prognostic Value of the WIfI Classification in Patients with Chronic Limb Threatening Ischaemia: A Systematic Review and Meta-Analysis October 1, 2019
    The Society for Vascular Surgery has proposed the Wound, Ischaemia, and foot Infection (WIfI) classification system as a prognostic tool for the one year amputation risk and the added value of revascularisation in patients with chronic limb threatening ischaemia (CLTI). This systematic review summarises the current evidence on the prognostic value of the WIfI classification […]
    N.S. van Reijen, K. Ponchant, D.T. Ubbink, M.J.W. Koelemay
  • Closed Incision Negative Pressure Wound Therapy in Vascular Surgery: A Systematic Review and Meta-Analysis October 1, 2019
    Closed incision negative pressure wound therapy (CiNPT) may be a valuable treatment option for surgical site infections. This systematic review and meta-analysis sought to compare CiNPT against conventional wound care after vascular procedures.
    I.J.Y. Wee, N. Syn, A.M.T.L. Choong
  • Characteristics of High Cost Inpatients With Peripheral Arterial Disease October 1, 2019
    Inpatient treatment of peripheral arterial disease (PAD) is over six times more costly than the general inpatient population. Our objective is to describe factors associated with cost for patients admitted for PAD, the characteristics of very high-cost patients, and their outcomes including amputations and death.
    Mark Rockley, Elizabeth Kunkel, Sudhir Nagpal, Danial I. McIssac, Kednapa Thavorn, Alan Forster, Daniel Kobewka
  • Safety and Effectiveness of Single Proglide Vascular Access in Patients Undergoing Endovascular Aneurysm Repair October 1, 2019
    To evaluate the safety and effectiveness of single Proglide use per access site for endovascular aneurysm repair (EVAR) of abdominal aortic aneurysms (AAA).
    Krista Dunn, Samuel Jessula, Christine R. Herman, Matthew Smith, Min S. Lee, Patrick Casey